Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: A study of patients receiving combined anakinra and methotrexate treatment

40Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Objectives: By MRI to assess the efficacy of addition of anakinra for controlling synovitis and stopping erosive progression in patients with clinically active RA despite receiving methotrexate, and to determine the predictive value of MRI for subsequent radiographic erosive progression. Methods: 100 mg anakinra subcutaneously/day was added to the treatment of 17 patients with clinically active RA despite methotrexate. MRI of the non-dominant wrist and 2nd-5th MCP joints (OMERACT evaluation) was performed at weeks 0, 12, and 36, and radiography of both hands and wrists (modified Sharp evaluation) at weeks 0 and 36. Results: MRI synovitis scores were not significantly changed. Radiography of both hands and wrists after 36 weeks showed erosive progression in 11 patients, and MRI after 12 weeks in 10 patients. Nine of 10 patients with MRI progression at 12 weeks had radiographic progression at 36 weeks. Baseline MRI synovitis and erosion scores, but no clinical/biochemical parameters, correlated significantly with subsequent erosive progression. Conclusion: Addition of anakinra did not significantly reduce MRI signs of synovitis, and most patients had progressive joint destruction. Baseline MRI findings predicted subsequent radiographic erosive progression. Unilateral wrist and MCP joint MRI after 12 weeks had a similar sensitivity for detection of erosive progression as bilateral hand and wrist radiography after 36 weeks.

References Powered by Scopus

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

19364Citations
N/AReaders
Get full text

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis

1474Citations
N/AReaders
Get full text

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

955Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Imaging in rheumatoid arthritis - status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography

136Citations
N/AReaders
Get full text

MRI of rheumatoid arthritis - Image quantitation for the assessment of disease activity, progression and response to therapy

132Citations
N/AReaders
Get full text

Monitoring anti-TNFα treatment in rheumatoid arthritis: Responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage

86Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Østergaard, M., Duer, A., Nielsen, H., Johansen, J. S., Narvestad, E., Ejbjerg, B. J., … Petersen, J. (2005). Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: A study of patients receiving combined anakinra and methotrexate treatment. Annals of the Rheumatic Diseases, 64(10), 1503–1506. https://doi.org/10.1136/ard.2005.038018

Readers over time

‘09‘10‘11‘13‘14‘16‘17‘18‘20‘21‘22‘23‘24036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

62%

Researcher 5

19%

Professor / Associate Prof. 3

12%

Lecturer / Post doc 2

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 20

74%

Pharmacology, Toxicology and Pharmaceut... 3

11%

Neuroscience 2

7%

Agricultural and Biological Sciences 2

7%

Save time finding and organizing research with Mendeley

Sign up for free
0